May 15, 2017
23:10
For every 10 shares held, investors received 23. The price per share adjusted from $37.88 to $16.47.
The split itself did not change the total investment value.
Realcan Pharmaceutical Group Co., Ltd. Class A (SZSE:002589) operates in the Pharmaceuticals: generic industry.
Realcan Pharmaceutical Group Co., Ltd. Class A company overviewRealcan Pharmaceutical Group Co., Ltd. Class A's most recent stock split was on May 15, 2017. It was a 23-for-10 forward split, so shareholders received 23 shares for every 10 they held.
Realcan Pharmaceutical Group Co., Ltd. Class A (SZSE:002589) has split its stock 3 times: a 2-for-1 split on July 14, 2014, a 2-for-1 split on October 9, 2015, and a 23-for-10 split on May 15, 2017.
Realcan Pharmaceutical Group Co., Ltd. Class A has split its stock 3 times. This history records 3 forward splits between July 14, 2014 and May 15, 2017.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Realcan Pharmaceutical Group Co., Ltd. Class A's 23-for-10 split on May 15, 2017, every 10 shares became 23 shares.
Realcan Pharmaceutical Group Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on May 15, 2017, 9 years ago. Companies announce splits in advance, and any new SZSE:002589 split will appear on this page.
Already premium?